Methoxyflurane inhalation - Medical Developments International

Drug Profile

Methoxyflurane inhalation - Medical Developments International

Alternative Names: Green whistle - Medical Developments International; ME-MEOTH; Penthrop; Penthrox; Penthrox 3ml inhalation vapour liquid

Latest Information Update: 24 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medical Developments International
  • Developer LINK Healthcare; Medical Developments International; Mundipharma International; Purdue Pharma
  • Class Fluorinated hydrocarbons; General anaesthetics; Methyl ethers; Muscle relaxants; Small molecules
  • Mechanism of Action GABA receptor modulators; Gap junction modulators; Glutamate receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 18 Oct 2017 Registered for Pain in Mexico (Inhalation)
  • 19 Jun 2017 Phase-III clinical trials in Pain in Spain (Inhalation) (EudraCT2017-000338-70)
  • 15 Jun 2017 Preregistration for Pain in Canada (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top